News
Resverlogix Corp. (TSX: RVX) ("Resverlogix", or the "Corporation") today held its Annual Meeting of Shareholders (the ...
Dr Asad Khan is a respiratory consultant who retired on ill-health grounds due to Long Covid. He spoke to Solidarity about ...
19h
Health on MSN9 Everyday Habits That Secretly Raise Your Blood PressureFactors such as diet, stress, sleep, and even hidden environmental triggers (such as air pollution) can contribute to ...
10h
StudyFinds on MSNCold Feet Could Signal Varicose Veins Years Before They ShowA massive study reveals that cold sensitivity in your extremities could predict varicose veins years before they become ...
Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...
India recorded around 14 lakh new cases and 917,000 deaths in 2022, with breast, oral, cervical, lung, and esophageal cancers leading ... Fellowship and International Fellowship in Vascular & ...
Loss of p300 in proximal tubular cells reduces renal fibrosis and endothelial-mesenchymal transition
Chronic kidney disease (CKD) is typically associated with severe fibrosis, the exact pathogenesis of which remains unclear.
Liquidia shipped its first FDA-approved product, Yutrepia for pulmonary hypertension in June entering market worth several ...
Resverlogix Corp. (TSX: RVX) ("Resverlogix", or the "Corporation") today held its Annual Meeting of Shareholders (the "Meeting") in Calgary, Alberta.
June is Men’s Health Month, an important annual campaign raising awareness about preventable health issues and encouraging ...
The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that has the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results